文献速递乳腺癌

MYC通过RNA降解与核糖核苷酸分解代谢在乳腺癌中诱导致癌应激

MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer.
PubMed 文献 · Cancer Discov · 2024-01-01

该研究揭示MYC上调通过细胞质外泌体增加RNA降解,导致细胞毒性RNA分解产物和活性氧积累,从而诱导癌细胞死亡;肿瘤来源的外泌体突变可消除MYC诱导的细胞死亡,嘌呤补救途径作为补偿性通路减轻MYC诱导的核糖核苷酸分解代谢,其抑制剂可损害MYC阳性肿瘤进展。

要点

  • MYC通过细胞质外泌体增加RNA降解,积累细胞毒性RNA分解产物和活性氧。
  • 肿瘤来源的外泌体突变可消除MYC诱导的细胞死亡。
  • 嘌呤补救途径抑制剂可损害MYC阳性肿瘤进展。

核心结论

  • MYC诱导的RNA降解是一种致癌应激,可利用于治疗。
  • 加剧下游核糖核苷酸分解代谢的治疗策略为三阴性乳腺癌和其他MYC驱动癌症提供了可治疗途径。

研究设计与样本

  • 研究结合遗传学与代谢组学,在乳腺癌中探索MYC诱导的RNA降解和核糖核苷酸分解代谢机制。

主要发现

  • MYC通过细胞质外泌体增加RNA降解,导致细胞毒性RNA分解产物和活性氧积累。
  • 肿瘤来源的外泌体突变可消除MYC诱导的细胞死亡。
  • 嘌呤补救途径作为补偿性通路减轻MYC诱导的核糖核苷酸分解代谢。
  • 嘌呤补救途径抑制剂损害MYC阳性肿瘤进展。

关键数值与推荐

  • MYC上调是癌症的标志,驱动致癌基因表达并提高癌细胞转录组的总RNA合成。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Upregulation of MYC is a hallmark of cancer, wherein MYC drives oncogenic gene expression and elevates total RNA synthesis across cancer cell transcriptomes. Although this transcriptional anabolism fuels cancer growth and survival, the consequences and metabolic stresses induced by excess cellular RNA are poorly understood. Herein, we discover that RNA degradation and downstream ribonucleotide catabolism is a novel mechanism of MYC-induced cancer cell death. Combining genetics and metabolomics, we find that MYC increases RNA decay through the cytoplasmic exosome, resulting in the accumulation of cytotoxic RNA catabolites and reactive oxygen species. Notably, tumor-derived exosome mutations abrogate MYC-induced cell death, suggesting excess RNA decay may be toxic to human cancers. In agreement, purine salvage acts as a compensatory pathway that mitigates MYC-induced ribonucleotide catabolism, and inhibitors of purine salvage impair MYC+ tumor progression. Together, these data suggest that MYC-induced RNA decay is an oncogenic stress that can be exploited therapeutically. Significance: MYC is the most common oncogenic driver of poor-prognosis cancers but has been recalcitrant to therapeutic inhibition. We discovered a new vulnerability in MYC+ cancer where MYC induces cell death through excess RNA decay. Therapeutics that exacerbate downstream ribonucleotide catabolism provide a therapeutically tractable approach to TNBC (Triple-negative Breast Cancer) and other MYC-driven cancers.

来源:Cancer Discov,查看原文。版权归原作者所有。

引用

  1. Meena JK, Wang JH, Neill NJ, et al. MYC Induces Oncogenic Stress through RNA Decay and Ribonucleotide Catabolism in Breast Cancer. Cancer Discov. 2024. PMID: 39193992. doi:10.1158/2159-8290.CD-22-0649

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。